Maximize therapeutic success with precision medicine
InsightRX is a precision dosing software platform that helps healthcare providers and life sciences organizations individualize drug therapy using model-informed precision dosing (MIPD). Founded in 2015 in San Francisco by Ron Keizer, Sirj Goswami, and Ranvir Mangat, the company's flagship product InsightRX Nova uses Bayesian pharmacokinetic modeling to provide bedside clinical decision support, while InsightRX Apollo delivers advanced PK/PD analytics. InsightRX has deployed its AI precision dosing software across more than 1,000 hospitals — more than any other vendor — and has earned a 96.1 KLAS score (vs. industry average of 80.6). The platform integrates with major EHR systems including Epic and helps clinicians reduce adverse drug events, optimize dosing regimens, and improve patient outcomes.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account